Tag Archives: Lead Director

Synovus Announces Changes to Board of Directors

By Business Wirevia The Motley Fool

Filed under:


Synovus Announces Changes to Board of Directors

COLUMBUS, Ga.–(BUSINESS WIRE)– Synovus Financial Corp. (NYS: SNV) , the Columbus, Georgia-based financial services company, today announced that its Board of Directors has nominated Barry L. Storey, founding partner of Hull Storey Gibson Companies, to stand for election at the company’s 2013 Annual Meeting of Shareholders, scheduled for April 25, 2013.

“Our board will benefit tremendously from Barry’s business expertise,” said Kessel Stelling, Chairman and Chief Executive Officer of Synovus. “In addition to building a successful real estate development company, he is a highly respected professional and community leader who will contribute greatly to the shaping of our company’s strategic direction.”

Storey, 53, helps guide Hull Storey Gibson Companies, LLC, an Augusta, Georgia-based real estate company, founded in 1992, that owns and operates more than 13 million square feet of retail strip centers and enclosed mall properties in the Southeast. He serves in a leadership capacity on several civic and professional boards, including as an Advisory Trustee of the University of Georgia Foundation, a member of the Dean’s Advisory Council of the University of Georgia‘s Terry College of Business, and as a director of the Community Foundation of the Central Savannah River Agency (CSRA). Storey is also a member of the advisory board of AFB&T, a division of Synovus Bank. He holds a bachelor’s degree from the University of Georgia.

Synovus also announced that the following two incumbent directors have reached the mandatory retirement age for Synovus directors and will not stand for re-election at the 2013 Annual Meeting of Shareholders:

Frank Brumley, who has served as a member of the Synovus Board of Directors since 2004, the last two years as Lead Director. He is the Chairman of the Board and Chief Executive Officer of Charleston, South Carolina-based Daniel Island Company, a planned community development company.

H. Lynn Page, who has served on the Synovus Board of Directors since 1978, including time as Vice Chairman. He spent more than 25 years in various executive positions at Synovus in Columbus, and was instrumental in the development of the company’s payment processing line of business.

“I am grateful for the dedicated board service and commitment to our company from Frank and Lynn,” said Stelling. “Frank’s extensive experience in banking and commercial real estate provided invaluable insight and expertise to our board, and Lynn’s many years of …read more

Source: FULL ARTICLE at DailyFinance

Covidien Announces Results from 2013 Annual General Meeting

By Business Wirevia The Motley Fool

Filed under:

Covidien Announces Results from 2013 Annual General Meeting

DUBLIN–(BUSINESS WIRE)– Covidien plc (NYS: COV) announced the results from today’s Annual General Meeting. Eight proposals were on the meeting agenda:

  • Election of Directors
  • Appointment of Independent Auditors
  • An advisory vote to approve the Company’s executive compensation
  • Approval of the amended and restated Covidien Stock and Incentive Plan
  • Authorization of the Company and/or any subsidiary to make market purchases of Company shares
  • Authorization of the reissue price range of treasury shares
  • Amendment of the Company’s Articles of Association to expand the authority to execute instruments of transfer, and
  • An advisory vote on the creation of distributable reserves for Mallinckrodt plc.

At the meeting, shareholders elected all 10 nominees, each of whom currently serves on Covidien’s Board of Directors. They are: José E. Almeida, Joy A. Amundson, Craig Arnold, Robert H. Brust, John M. Connors, Jr., Christopher J. Coughlin, Randall J. Hogan, III, Martin D. Madaus, Dennis H. Reilley and Joseph A. Zaccagnino. In addition, the Directors elected Mr. Reilley to be the Lead Director, replacing Timothy M. Donahue, who did not stand for reelection to the Board.

Shareholders also approved the appointment of Deloitte & Touche LLP to serve as the Company’s independent auditors, and, in an advisory vote, approved the Company’s executive compensation. Shareholders approved the amended and restated Covidien Stock and Incentive Plan, authorized Covidien and/or any of its subsidiaries to make market purchases of Company shares and authorized the price range at which the Company can reissue shares it holds as treasury shares. In addition, shareholders also approved an amendment to Covidien’s Articles of Association to expand the authority to execute instruments of transfer and, in an advisory vote, approved the creation of distributable reserves for Mallinckrodt plc.

About Covidien

Covidien is a leading global healthcare products company that creates innovative medical solutions for better patient outcomes and delivers value through clinical leadership and excellence. Covidien manufactures, distributes and services a diverse range of industry-leading product lines in …read more
Source: FULL ARTICLE at DailyFinance